Viewing Study NCT00090012


Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2025-12-31 @ 11:21 AM
Study NCT ID: NCT00090012
Status: COMPLETED
Last Update Posted: 2007-11-06
First Post: 2004-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module